Indiana injury law does not treat every harm the same way. A person hurt by a prescription drug, a person hurt by a doctor’s mistake, and a person hurt by a commercial delivery vehicle may all suffer serious and lasting injuries, yet each claim travels through a different statute, a different set of procedures, and often a different courthouse. Those differences carry real weight. They affect when a claim must be filed, whether a lawsuit can begin right away, how much money is available, and who ends up paying.
These three categories also happen to be growing at the same time. Prescription weight-loss and diabetes drugs are now used by millions of Americans, outpatient medical care continues to expand, and residential streets carry more delivery vans and box trucks than ever. Looking at the three side by side shows how much the source of an injury shapes everything that follows.
Pharmaceutical Claims and the GLP-1 Litigation
Drug injury claims in Indiana fall under the Indiana Product Liability Act, which governs claims against manufacturers for defective products, including failures to provide adequate warnings. Interest in this area has grown with the expanding use of GLP-1 receptor agonists such as semaglutide and dual-action drugs such as tirzepatide, sold as Mounjaro and Zepbound. Claimants who file a tirzepatide lawsuit today will most likely see it join the federal multidistrict litigation in the Eastern District of Pennsylvania, MDL No. 3094, which collects cases alleging gastrointestinal injuries such as gastroparesis, ileus, and intestinal obstruction. The court has confirmed that Zepbound falls within its scope.
The MDL has grown to roughly 4,000 pending cases as of fall 2026, and it is currently in the expert and summary judgment phase, with no bellwether trial yet held. Plaintiffs claiming gastroparesis have been required to support the diagnosis with objective testing, such as a gastric emptying study. A separate MDL, No. 3163, was created in late 2025 for claims alleging vision loss from a condition called NAION. All of these claims remain allegations, and the manufacturers dispute them.
Failure to Warn and the Prescribing Doctor
Most prescription drug claims turn on warnings. Indiana applies the learned intermediary doctrine, under which a drug manufacturer’s duty to warn generally runs to the prescribing physician, who stands between the manufacturer and the patient. A claim therefore often asks what the label told doctors about a particular risk and when, and whether a better warning would have changed the prescribing decision. Indiana product liability claims generally must be filed within two years after the cause of action accrues and within 10 years after the product was delivered to the initial user, subject to limited exceptions.
Medical Negligence Under the Indiana Medical Malpractice Act
Claims against health care providers follow a very different path. Indiana’s Medical Malpractice Act applies to providers who qualify by carrying specified insurance and paying into the state’s Patient’s Compensation Fund, and most physicians and hospitals in the state participate. For claims above $15,000 against qualified providers, the Act generally requires that a proposed complaint be submitted to the Indiana Department of Insurance and reviewed by a medical review panel before the case can proceed to trial. The panel consists of three health care providers and a non-voting attorney chair, and its opinion on whether the standard of care was met can be introduced as evidence later.
The Act also caps total damages. For acts of malpractice occurring on or after July 1, 2019, total recovery is limited to $1.8 million, with an individual provider responsible for up to $500,000 and the Patient’s Compensation Fund paying amounts above that, up to the cap. People who speak with medical malpractice lawyers indianapolis indiana residents have consulted typically hear early about the panel process, since it can add a year or more to the timeline before a case reaches a jury.
Where Drug Claims and Malpractice Claims Overlap
Here’s the kicker though. A single drug-related injury can raise both kinds of claims. A patient who develops a serious complication might argue that the manufacturer failed to warn about the risk, and also that the prescriber ignored known contraindications or failed to monitor symptoms. Those claims follow separate statutes. The claim against the manufacturer goes forward under product liability law, while the claim against the doctor must go through the medical review panel. The interaction becomes more complicated with compounded versions of these drugs, which some patients obtained during shortages, since compounding pharmacies are not the original manufacturers and their products are not approved by the FDA in the same way.
The Medical Malpractice Act uses an occurrence-based limitations rule, requiring claims to be filed within two years of the alleged act or omission. Indiana courts have recognized constitutional limits on that rule when a patient could not reasonably have discovered the malpractice within the two-year period, but the general rule remains strict, and timing questions come up frequently.
Delivery Truck Crashes
Crashes involving delivery vehicles follow the ordinary negligence framework, but the vehicles and the business arrangements behind them create their own complications. Delivery fleets range from small cargo vans to box trucks and full tractor-trailers. Federal motor carrier safety rules generally apply to vehicles over 10,001 pounds operating in interstate commerce, which means some delivery vans fall outside many federal requirements while larger trucks fall within them.
Funny thing is, the company whose logo appears on a delivery van is not always the driver’s employer. Large retailers and shipping companies often work through contracted delivery service providers, and the legal relationship among the brand, the contractor, and the driver affects who can be held responsible. An injured person evaluating a crash with an indiana delivery truck accident lawyer usually starts by identifying the employer and the insurance policies that apply, since a contractor’s coverage may differ significantly from the brand company’s.
Delivery work also creates distinctive crash patterns. Drivers make dozens of stops per shift, park in travel lanes, back up in residential streets, and operate under tight time targets. Pedestrians and children in neighborhoods are particularly exposed to backing incidents. Telematics systems used by many fleets record speed, braking, and location, and that data can become important evidence when fault is disputed.
Delivery companies also face claims tied to their own practices. A contractor that pushes route quotas high enough to encourage speeding, skips vehicle maintenance, or hires drivers with poor records may be responsible for its own negligence alongside the driver’s. Records such as route plans, delivery scan times, and maintenance logs often show how the work was actually organized on the day of the crash.
Fault and Insurance in Crash Cases
Indiana follows modified comparative fault, barring recovery when the injured person’s fault is greater than the combined fault of the other parties and reducing recovery by the injured person’s percentage otherwise. Most crash claims must be filed within two years. No damages cap applies to ordinary vehicle negligence cases, which stands in sharp contrast to the medical malpractice framework.
Three Paths From One Starting Point
Every injury begins with the same basic question of who caused the harm, but in Indiana the answer immediately sends the case down one of several very different roads. A drug claim may join thousands of others in a federal courtroom in another state. A malpractice claim waits for a panel of physicians to weigh in. A delivery crash depends on sorting out contracts between companies the injured person may never have heard of. The injury itself may feel the same from the inside, yet the law that responds to it changes with its source.